Squamosamide Derivative FLZ Protects Pancreatic β-Cells from Glucotoxicity by Stimulating Akt-FOXO1 Pathway
Chronic hyperglycemia increases apoptosis and reduces glucose-stimulated insulin secretion. Although protective agents have been searched extensively, none has been found so far. Here we tested FLZ, a synthetic derivative of squamosamide from a Chinese herb, as a potential candidate for antiglucotox...
Main Authors: | Xiangchen Kong, Longmei Zhang, Xianxin Hua, Xiaosong Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2015/803986 |
Similar Items
-
Squamosamide Derivative FLZ Diminishes Aberrant Mitochondrial Fission by Inhibiting Dynamin-Related Protein 1
by: Hanyu Yang, et al.
Published: (2021-03-01) -
Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity
by: Wilson Belinda, et al.
Published: (2008-05-01) -
Squamosamide Derivative FLZ Protects Retinal Pigment Epithelium Cells from Oxidative Stress through Activation of Epidermal Growth Factor Receptor (EGFR)-AKT Signaling
by: Li-Bo Cheng, et al.
Published: (2014-10-01) -
Protection of Rat Pancreatic β cells Against Glucotoxicity by Rutin and EGCG
by: Pei-Shan Cai, et al.
Published: (2008) -
Glucotoxicity in Insulin-Producing β-Cells
by: Nyblom, Hanna K
Published: (2007)